Australia adds esketamine nasal spray for treatment-resistant depression
Beginning May 1, 2025, Australians suffering from treatment-resistant depression will have access to a new medication, esketamine, under the Pharmaceutical…
Позначка: esketamine
Esketamine with SNRI reduces treatment-resistant depression risks
Major depressive disorder (MDD) impacts about 280 million individuals worldwide, making it a leading cause of disability and diminished quality…
Ukrainian 
English 
French 
German 
Russian 
Spanish 
Belarusian